Leukemia & Lymphoma Society: Translational Research Program

The Leukemia and Lymphoma Society is accepting applications from investigators that will put them on the bench-to-bedside fast track for finding better treatments and cures for leukemia, lymphoma and myeloma. Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Award amount is up to $200,000 over three years. The letter of intent deadline is Jan. 13, 2017.

The Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Leukemia & Lymphoma Society: Translational Research Program
http://www.lls.org

The Leukemia and Lymphoma Society (LLS) is accepting applications from investigators that will put them on the bench-to-bedside fast track for finding better treatment and cures for leukemia, lymphoma and myeloma. Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions.

Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical translation of the studies proposed and the results expected. This feature will be an important consideration of the review process. This program is intended to provide support over an initial three-year period. Two additional years may be available through the competitive, peer-reviewed TRP Renewal process to solidify progress made in the initial award and further support a clinical trial. To be considered for a TRP renewal award, a clinical protocol for a Phase I or Phase II clinical trial based on the initial Translational Research Program grant must be submitted to the institution’s IRB for approval and the work must be a direct result of the funded TRP award (see Renewal Guidelines and Instructions for detailed information).

LLS welcomes applications from both US citizens and non-citizens, as well as applicants who are performing research outside the U.S. Applicants must hold a PhD, MD, DVM or equivalent degree. A Principal Investigator may only submit ONE application per application cycle and cannot serve as a Principal Investigator OR Co-Principal Investigator on more than ONE application per cycle.

LOI Deadline: Jan. 13, 2017 by 3:00 p.m. Invited full proposals will be due March 1, 2017 by 3:00 p.m. with award notification by June 30, 2017 and an award start date of October 1, 2017. Application Guidelines for the award: http://www.lls.org/research/translational-research-program

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. If you have any questions about this funding opportunity, please email cfr@unc.edu or phone 919-962-2867.

Filed under: